AOD-9604

A modified fragment of human growth hormone (hGH 176-191), AOD-9604 specifically targets fat metabolism without affecting blood sugar or growth. It stimulates lipolysis and inhibits lipogenesis.
Tesamorelin

An FDA-approved growth hormone-releasing hormone (GHRH) analog, Tesamorelin is particularly effective at reducing visceral adipose tissue. It stimulates the pituitary gland to produce natural GH.
GLP-3 (Oxyntomodulin)

GLP-3, also known as Oxyntomodulin, is a dual agonist that activates both GLP-1 and glucagon receptors. It provides powerful metabolic benefits including fat loss, appetite suppression, and increased energy expenditure, making it a next-generation metabolic peptide.
GLP-1 (Semaglutide/Liraglutide)

Glucagon-like peptide-1 receptor agonists are a breakthrough class of metabolic peptides that mimic the natural GLP-1 hormone, regulating blood sugar, suppressing appetite, and driving significant fat loss. FDA-approved for obesity and type 2 diabetes management.